Friday 6 November 2026 Export ETON’s income statement to Excel — free account

Eton Pharmaceuticals, Inc.

ETON Healthcare Drug Manufacturers Specialty & Generic

Eton Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $80.0 million, up 104.9% from fiscal 2024.

Revenue: +157.9%
EPS: +1,857.1%
Free cash flow: +172.6%
Total debt: −24.0%

Quarter to September 2026, against a year earlier

Revenue growth 3 yrs

54.21 7.06 +14.97%

Follow ETON

Alert me

Market cap: $1.4B
P/E: 26.8×
Fwd P/E: 48.0×
Dividend yield: —
F-score: 5/9
Altman Z: 3.55
Beneish M: −2.24
Dividend safety: n/a

Overview

	Sep '26 From the 10-Q filed 5 Nov	Jun '26	Mar '26	Dec '25	Older periods
Piotroski F-Score Full definition →	7	6	5	5	+8 more TTM periods Free account
ROE Full definition →	90.62%	35.97%	(5.36%)	(18.19%)
ROA Full definition →	38.10%	11.67%	(1.62%)	(5.47%)
ROIC Full definition →	46.77%	21.39%	3.06%	(1.71%)
Return on Tangible Assets Full definition →	115.90%	53.25%	(15.63%)	(20.52%)
Average Days of Receivables Full definition →	68.38	86.02	56.29	53.67
Free Cash Flow per Share Full definition →	0.70	(0.30)	(0.28)	0.38
Free Cash Flow Full definition →	19.99	(8.39)	(7.70)	10.18
Capital Expenditures Full definition →	(18.36)	(23.52)	(23.54)	(0.34)
Other line items
Cash ROIC Full definition →	12.07%	(8.28%)	(9.50%)	12.32%
Accounts Receivable Turnover Full definition →	7.14	5.37	5.83	9.34
Accounts Payable Turnover Full definition →	2.83	3.35	4.28	4.91
Inventory Turnover Full definition →	3.12	2.62	2.80	2.43
Average Days of Payables Full definition →	138.40	118.17	125.18	107.67
Days of Inventory on Hand Full definition →	92.96	83.21	134.29	151.25
Tax Rate Full definition →	0.35	0.00	(0.01)	0.01
Research and Development Expense of Revenue Full definition →	7.03%	5.45%	9.75%	9.71%
Selling, General and Administrative Expense of Revenue Full definition →	33.28%	36.97%	42.67%	44.80%
Share Based Compensation of Revenue Full definition →	5.26%	4.93%	6.71%	6.89%
Interest Coverage Full definition →	12.86	4.59	0.58	—
Operating CF/Net income Full definition →	0.77	1.19	(10.74)	(2.29)
Depreciation/Fixed assets Full definition →	16.69	14.70	12.59	14.54
Capex/Depreciation Full definition →	(3.25)	(4.55)	(5.03)	(0.07)
Revenue per Share Full definition →	4.92	3.82	3.19	2.97
Operating CF per Share Full definition →	1.34	0.55	0.58	0.39
Capex per Share Full definition →	(0.64)	(0.85)	(0.86)	(0.01)
Capex to Sales Full definition →	0.13	0.22	0.27	0.00

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly